The aim of the meeting is to provide an in-depth overview and critical assessment of the latest development and future directions in the management of haematological tumours with a focus on the role of neuroimaging in general and nuclear medicine in particular. The goal is to arrive at a multidisciplinary consensus on the current state of the art and to make expert recommendations on how to advance the field towards establishing clinical impact.